immune system
| N |
• no immune system abnormalites are detected
(J:60782)
|
|
hm1
|
Tap1tm1Hpl/Tap1tm1Hpl
either: (involves: 129S2/SvPas * 129/Ola) or (involves: 129S2/SvPas * FVB) |
|
|||||||||||||||||
| N |
• no immune system abnormalites are detected
(J:60782)
|
|
cx2
|
B2mtm1Jae/B2mtm1Jae Tap1tm1Hpl/Tap1tm1Hpl B6.129-B2mtm1Jae Tap1tm1Hpl |
|
|||||||||||||||||
|
• 52% of P13 mice and 57% of adult mice have enlarged lateral ventricles
|
|
• area of the ipsilateral projection is increased compared to controls
• in some cases, multiple ectopic clusters of inputs are present in the medial areas of the LGN
• retinogeniculate axons, glomeruli and bouton appear normal
|
|
• increase in size of excitatory presynaptic boutons
|
|
• mice exhibit significantly fewer perforations at hippocampal synapses that wild-type
|
|
• presynaptic nerve terminals contain 10% more synaptic vesicles than wild-type
|
|
• LTP in response to tetanus is enhanced by approximately 227% as compared to wild type
|
|
• 40% increase in frequency in hippocampal neurons
• 100% increase in frequency in layer 4 cortical neurons
• median amplitude is similar to wild-type in hippocampal and layer 4 neurons
• treatment with the neural activity blocker, Tetrodotoxin (TTX), does not increase mEPSC in mutant hippocampal cultures in contrast to increases in both amplitude and frequency observed in wild-type
|
|
• 900 pulses at 1 Hz enhances baseline LTD, but LTD is unchanged in wild-type
|
|
• 900 pulses at 0.5 Hz does not induce significant LTD in contrast to wild-type response
|
|
cx3
|
Msh2tm1Htr/Msh2tm1Htr Tap1tm1Hpl/Tap1tm1Hpl involves: 129P2/OlaHsd * FVB |
|
|||||||||||||||||
|
• mice that survive beyond 30 weeks exhibit a multitude of tumors types (erythroid, intestine, skin, uterus, mammary gland, lung, intestine, and hereditary nonpolyposis colorectal cancer)
|
|
• in mice that survive beyond 30 weeks
|
|
• 80% of mice that survive beyond 30 weeks develop Hereditary Nonpolyposis Colon Cancer (HNPCC) tumors
|
|
• in mice that survive beyond 30 weeks
|
|
|
• in mice that survive beyond 30 weeks
(J:45433)
|
|
• in mice that survive beyond 30 weeks
|
|
• in mice that survive beyond 30 weeks
|
Mouse Models of Human Disease |
OMIM ID | Ref(s) | |
| Lynch Syndrome I | 120435 | J:45433 | |